Development, of a tool for predicting bleeding in patients with Dengue fever for optimizing transfusion therapy in Dengue

Development, validation and real-world impact of bleeding prediction models for optimizing transfusion therapy in Dengue - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081827

Enrollment

918

Registered

2025-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A90- Dengue fever [classical dengue]

Interventions

Intervention1: Bleeding Prediction tool incoporating Thromboelastography test: The bleeding prediction tool will be designed using statistical modelling of the phase 1 data collection which may includ

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with Fever with Thrombocytopenia and having positive Dengue card test (NS1/IgM) on screening

Exclusion criteria

Exclusion criteria: Known coagulation disorder Patient on anticoagulant medications Patients with active bleeding at the time of admission

Design outcomes

Primary

Measure	Time frame
Bleeding (except petechiae & minor mucosal bleed)Timepoint: 48 hours from recruitment	—

Secondary

Measure	Time frame
Blood Product transfusion (RDP)Timepoint: 48 hours from recruitment	—

Countries

India

Contacts

Public ContactRachana

Kasturba Medical College, Manipal

nityanitingupta@gmail.com9868996079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026